Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes

International Journal of Pharmaceutics

Volumn 349, Issue 1-2, 2008, Pages 38-46

  Woo, Janet ^a,b   Chiu, Gigi N C ^c   Karlsson, Göran ^d   Wasan, Ellen ^a,b   Ickenstein, Ludger ^d   Edwards, Katarina ^d   Bally, Marcel B ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cisplatin; Drug release; Passive equilibration; Thermosensitive liposomes

Indexed keywords

CISPLATIN; LIPOSOME;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL ASSESSMENT; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG SYNTHESIS; ENCAPSULATION; HEAT SENSITIVITY; HYPERTHERMIA; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TEMPERATURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; CISPLATIN; CRYOELECTRON MICROSCOPY; DRUG CARRIERS; DRUG COMPOUNDING; HEAT; LIPOSOMES; MEMBRANES, ARTIFICIAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PERMEABILITY; SOLUBILITY; TEMPERATURE;

EID: 37449033076     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.07.020     Document Type: Article

References (37)

1. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
2. Almgren M., Edwards K., and Gustafsson J. Cryo-transmission electron microscopy of thin vitrified samples. Curr. Opin. Colloid Interface Sci. 1 (1996) 270-278
3. Anyarambhatla G.R., and Needham D. Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: a new temperature-sensitive liposome for use with mild hyperthermia. J. Liposome Res. 9 (1999) 491-506
4. Bandak S., Goren D., Horowitz A., Tzemach D., and Gabizon A. Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. Anticancer Drugs 10 (1999) 911-920
5. Bittman R., Clejan S., Fugler L., and Rosenthal A.F. The effect of cholesterol on glycerophosphono- and glycerophosphinocholines. Permeability measurements in lipid vesicles. Biochim. Biophys. Acta 855 (1986) 265-270
6. Chen Q., Tong S., Dewhirst M.W., and Yuan F. Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol. Cancer Ther. 3 (2004) 1311-1317
7. Derksen J.T., Morselt H.W., and Scherphof G.L. Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim. Biophys. Acta 931 (1987) 33-40
8. Dewhirst M.W. Future directions in hyperthermia biology. Int. J. Hyperthermia 10 (1994) 339-345
9. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51 (1999) 691-743
10. Einhorn L.H., and Williams S.D. The role of cis-platinum in solid-tumor therapy. N. Engl. J. Med. 300 (1979) 289-291
11. Goto H., Yano S., Matsumori Y., Ogawa H., Blakey D.C., and Sone S. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin. Clin. Cancer Res. 10 (2004) 7671-7676
12. Grit M., and Crommelin D.J. Chemical stability of liposomes: implications for their physical stability. Chem. Phys. Lipids 64 (1993) 3-18
13. Harrington K.J., Lewanski C.R., Northcote A.D., Whittaker J., Wellbank H., Vile R.G., Peters A.M., and Stewart J.S. Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer. Ann. Oncol. 12 (2001) 493-496
14. Hope M.J., Bally M.B., Webb G., and Cullis P.R. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 812 (1985) 55-65
15. Ickenstein L.M., Arfvidsson M.C., Needham D., Mayer L.D., and Edwards K. Disc formation in cholesterol-free liposomes during phase transition. Biochim. Biophys. Acta 1614 (2003) 135-138
16. Kong G., and Dewhirst M.W. Hyperthermia and liposomes. Int. J. Hyperthermia 15 (1999) 345-370
17. Kong G., Anyarambhatla G., Petros W.P., Braun R.D., Colvin O.M., Needham D., and Dewhirst M.W. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 60 (2000) 6950-6957
18. Lim H.J., Masin D., Madden T.D., and Bally M.B. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone. J. Pharmacol. Exp. Ther. 281 (1997) 566-573
19. Lim H.J., Masin D., McIntosh N.L., Madden T.D., and Bally M.B. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors. J. Pharmacol. Exp. Ther. 292 (2000) 337-345
20. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000) 271-284
21. Meerum Terwogt J.M., Groenewegen G., Pluim D., Maliepaard M., Tibben M.M., Huisman A., ten Bokkel Huinink W.W., Schot M., Welbank H., Voest E.E., Beijnen J.H., and Schellens J.M. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin. Cancer Chemother. Pharmacol. 49 (2002) 201-210
22. Needham D., and Dewhirst M.W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv. Drug Deliv. Rev. 53 (2001) 285-305
23. Needham D., Anyarambhatla G., Kong G., and Dewhirst M.W. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 60 (2000) 1197-1201
24. Newman M.S., Colbern G.T., Working P.K., Engbers C., and Amantea M.A. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother. Pharmacol. 43 (1999) 1-7
25. Olson F., Hunt C.A., Szoka F.C., Vail W.J., and Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 557 (1979) 9-23
26. Peleg-Shulman T., Gibson D., Cohen R., Abra R., and Barenholz Y. Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance. Biochim. Biophys. Acta 1510 (2001) 278-291
27. Ponce A.M., Viglianti B.L., Yu D., Yarmolenko P.S., Michelich C.R., Woo J., Bally M.B., and Dewhirst M.W. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J. Natl. Cancer Inst. 99 (2007) 53-63
28. Sandstrom M.C., Ickenstein L.M., Mayer L.D., and Edwards K. Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes. J. Control. Release 107 (2005) 131-142
29. Shabbits J.A., Chiu G.N., and Mayer L.D. Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems. J. Control. Release 84 (2002) 161-170
30. Song C.W., Kang M.S., Rhee J.G., and Levitt S.H. Effect of hyperthermia on vascular function in normal and neoplastic tissues. Ann. NY Acad. Sci. 335 (1980) 35-47
31. Valdagni R., and Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int. J. Radiat. Oncol. Biol. Phys. 28 (1994) 163-169
32. Valdagni R., Amichetti M., and Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 15 (1988) 13-24
33. van der Zee J. Heating the patient: a promising approach?. Ann. Oncol. 13 (2002) 1173-1184
34. Weinstein J.N., Magin R.L., Yatvin M.B., and Zaharko D.S. Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science 204 (1979) 188-191
35. Xiang T.X., and Anderson B.D. Influence of chain ordering on the selectivity of dipalmitoylphosphatidylcholine bilayer membranes for permeant size and shape. Biophys. J. 75 (1998) 2658-2671
36. Yap R., Veliceasa D., Emmenegger U., Kerbel R.S., McKay L.M., Henkin J., and Volpert O.V. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy. Clin. Cancer Res. 11 (2005) 6678-6685
37. Yatvin M.B., Weinstein J.N., Dennis W.H., and Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202 (1978) 1290-1293